Format:
1 Online-Ressource (626 pages)
ISBN:
9783319452371
Content:
Preface -- Contents -- Part I: New Concepts on Epidemiology and Mechanisms of Heart Failure -- Chapter 1: Prevalence, Incidence and Lifetime Risk of Heart Failure -- Lifetime Risk -- Prevalence of Heart Failure -- Asymptomatic Left Ventricular Dysfunction -- Heart Failure with Reduced Versus Preserved Ejection Fraction -- Incidence of Heart Failure -- References -- Chapter 2: Evolving Concepts on the Basic Mechanisms of Heart Failure -- The Current Heart Failure Mechanisms in Heart Failure with Reduced Ejection Fraction (HFrEF) -- The Pump Failure -- The Role of Neurohormones -- The Kidney: Responsible for HF -- Loss of Cardiac Myocytes -- Dysfunctional Cardiac Myocytes due to Abnormal Cytoplasmic Ca2+ Homeostasis -- The Myocardial Extracellular Matrix -- Genes Contribution -- Heart Failure with Preserved Ejection Fraction (HFpEF) -- From Left to Right Heart Failure -- Noncardiac Comorbidities and HF -- References -- Part II: The Role of Cardiac Imaging in the Evaluation of Heart Failure -- Chapter 3: Assessment of Left Ventricular Systolic and Diastolic Function by Echocardiography -- Introduction -- Assessment of Left Ventricular Systolic Function -- Left Ventricular Fractional Shortening -- Left Ventricular Ejection Fraction -- 2D Echocardiography -- 3D Echocardiography -- Data Acquisition -- Analysis -- Stroke Volume and Cardiac Output -- LV Regional Function -- Doppler Methods of LV Systolic Function Evaluation -- Rate of LV Pressure Increase -- Myocardial Deformation Imaging -- Assessment of Left Ventricular Diastolic Function -- Echocardiographic Diagnosis of LVDD in Patients with HFpEF -- Echocardiographic Assessment of Left Ventricular Filling Pressures and Diastolic Dysfunction Grade -- References -- Chapter 4: The Imaging of Right Ventricular Dysfunction in Heart Failure -- Introduction -- Echocardiography
Content:
Standard Echocardiographic Views of the RV -- Right Ventricular Global Systolic Function -- Conventional 2DE Parameters -- 3DE Assessment of the RV Systolic Function -- Right Ventricular Regional Systolic Function -- RV Diastolic Function -- Right Ventricular Mechanics -- RV Dyssynchrony -- Cardiac Magnetic Resonance -- RV Global Systolic Function -- RV Regional Systolic Function -- RV Myocardial Mechanics -- Computed Tomography -- Nuclear Imaging -- Conclusions -- References -- Chapter 5: The Role of Atrial Functional Assessment in Heart Failure -- Left Atrial Function -- Echocardiographic Assessment of Left Atrial Function -- Left Atrial Function and Heart Failure -- Conclusion -- References -- Chapter 6: Assessment of Secondary Mitral Regurgitation -- Introduction -- Definition, Mechanisms, and Physiopathology -- Echocardiographic Assessment of SMR -- Diagnosis and Mechanism of SMR -- Valve Morphology: Overall Assessment -- Valve Morphology: Quantitative Analysis of Mitral Valve Deformation -- LV Remodeling Assessment -- Quantification of SMR Severity -- 2D Echocardiography -- 3D Echocardiography -- The Dynamic Nature of Chronic Ischaemic MR: Role of Stress Echocardiography -- Role of 3D During MitraClip Therapy -- References -- Chapter 7: Left Ventricular Contactile Reserve -- Introduction -- Contractility Indices -- Stroke Volume and Ejection Fraction -- LV Longitudinal Function -- Future Directions and Possible Developments -- Bibliography -- Chapter 8: Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure -- Cardiovascular Magnetic Resonance Techniques -- Functional Imaging (cine-CMR) -- Flow CMR -- Myocardial Perfusion Imaging (MPI) -- Myocardial Tissue Characterization -- Evolving CMR Techniques -- Safety and Limitations -- The Role of CMR in Suspected or Confirmed Heart Failure -- Ischemic Cardiomyopathy
Content:
Myocardial Infarction -- Ischemia Testing -- Viability Assessment -- Non-ischemic Cardiomyopathies -- Cardiomyopathies Presenting Mostly with a Hypertrophic Phenotype -- Hypertrophic Cardiomyopathy -- Amyloidosis -- Cardiomyopathies Presenting Mostly with a Dilative Phenotype -- Dilated Cardiomyopathy -- Iron Overload Cardiomyopathy -- Cancer Therapy Related Cardiomyopathies -- Muscular Dystrophy -- Arrhythmogenic Right Ventricular Cardiomyopathy -- Inflammatory Diseases and Other Cardiomyopathies -- Acute Myocarditis -- Sarcoidosis -- Systemic Inflammatory Diseases -- Left Ventricular Non-compaction -- Takotsubo Cardiomyopathy -- Valvular Heart Disease -- Adult Congenital Heart Disease -- Pericardial Disease -- The Role of CMR in Guiding Implantable Cardioverter-Defibrillator (ICD)/Cardiac Resynchronization (CRT) Therapy -- ICD -- CRT -- References -- Chapter 9: The Evolving Role of Multimodality Imaging in Heart Failure -- Imaging of Ischemia: Risk Area and Coronary Arteries -- Metabolic Imaging -- Molecular Imaging: The Evaluation of Cardiac Innervation -- Innervation Imaging of Arrhythmias -- Cardiac Resynchronization Therapy -- Rheumatic Disease -- Management of Aortic Stenosis in HF -- Cardio-oncology and HF -- Cardiac Amyloidosis -- Quantitative Cardiac Imaging: The Need for an Absolute Measurement of Cardiac Parameters -- Future Perspectives-Hybrid Imaging Using Molecular Targets -- Conclusion -- References -- Part III: Treatment of Heart Failure -- Chapter 10: Contemporary Pharmacological Treatment of Heart Failure -- The Goals of Treatment -- Pharmacological Treatment in Chronic Heart Failure -- Heart Failure with Reduced Ejection Fraction -- Treatments Improving the Outcomes -- Treatments Recommended in All Patients with HFrEF- Neurohormonal Antagonists -- Angiotensin- Converting Enzyme Inhibitors -- Beta- Blockers
Content:
Mineralocorticoid Receptor Antagonists -- Treatments Recommended in Selected Symptomatic Patients -- Diuretics -- Angiotensin Receptor Neprilysin Inhibitor -- If- Channel Inhibitor -- Angiotensin II Type I Receptor Blockers -- Combination of Hydralazine and Isosorbide Dinitrate -- Digoxin and Other Digitalis Glycosides -- Heart Failure with Preserved and with Mid- Range Ejection Fraction -- References -- Chapter 11: Myocardial Revascularization in Heart Failure -- Background -- Revascularization for Treatment of Angina Pectoris -- Revascularization for Prognostic Purposes -- The Role of Myocardial Viability -- Similar Value of Percutaneous Coronary Intervention? -- What Do the Guidelines Tell Us? -- Conclusion -- References -- Chapter 12: Approach to Arrhythmia in Heart Failure -- Introduction -- Brady-Arrhythmias in Heart Failure -- Approach to Supraventricular Arrhythmias -- Epidemiology of Atrial Fibrillation in Heart Failure -- Mechanisms of Atrial Fibrillation Occurrence in Heart Failure -- Treatment of Atrial Fibrillation in Heart Failure -- Prevention of Thromboembolism -- Acute Management of Atrial Fibrillation in Acute Heart Failure -- Rate Control: Pharmacological and Interventional Treatments -- Rhythm Control: Pharmacological and Interventional Treatment -- Other Supraventricular Arrhythmias in Heart Failure -- Ventricular Arrhythmias -- Epidemiology of Ventricular Arrhythmias in Heart Failure -- Mechanisms of Ventricular Arrhythmias in Heart Failure -- Treatment of Ventricular Arrhythmias in Heart Failure -- Prevention of Sudden Cardiac Death in Heart Failure -- Pharmacological Treatment for Ventricular Arrhythmias -- Interventional Treatments for Ventricular Arrhythmias -- Arrhythmias in Heart Failure with Preserved Ejection Fraction -- References -- Chapter 13: Devices for Heart Failure: Implantable Cardioverter Defibrillator
Content:
Epidemiology of Heart Failure: Insight into the Device Therapy -- Evolution of the Implantable Cardioverter Defibrillator from Thoracotomy to the Subcutaneous Implantable Defibrillator -- Current Tendencies in the Treatment of Heart Failure (Prevention of Sudden Cardiac Death): From Optimal Medical Therapy to the Idea of Implantable Cardioverter Defibrillators -- Prevention of Sudden Cardiac Death Among Heart Failure Patients -- Secondary Prevention of Sudden Cardiac Death Among Heart Failure Patients -- Primary Prevention of Sudden Cardiac Death Among Heart Failure Patients -- Cardiac Dyssynchrony -- The Concept of Biventricular Pacing: Cardiac Resynchronization Therapy -- The Concept and Rational of the Subcutaneous Implantable Defibrillators -- Peri- and Post-procedural Complications of Implantable Cardioverter Defibrillators Implantation -- References -- Chapter 14: Cardiac Resynchronization Therapy -- Introduction -- Pathophysiology of Cardiac Dyssynchrony. Dyssynchrony Assessment -- Imaging in Cardiac Resynchronization Therapy -- Clinical Evidence in Cardiac Resynchronization Therapy and Current Guidelines. -- Response to CRT: Patient Selection and Improving CRT Delivery -- Conclusion -- References -- Chapter 15: Mechanical Circulatory Support -- Introduction and Epidemiology -- Acute (Temporary) Mechanical Circulatory Support Devices -- Durable (Permanent) Ventricular Assist Devices -- Underlying Physiologic Principles of Continuous Flow Devices -- Patient Selection -- Current Clinical Results with Continuous Flow Pumps -- In Hospital Management -- Long-Term Management -- Management of Ventricular Assist Device Long-Term Complications -- Management of Gastrointestinal Bleeding -- Management of Infections -- Management of Atrial and Ventricular Arrhythmias -- Management of de Novo Aortic Insufficiency
Content:
Management of Pump Thrombosis and Pump Malfunction
Additional Edition:
9783319452364
Additional Edition:
Print version Dorobanţu, Maria Current Approach to Heart Failure Cham : Springer International Publishing,c2016 9783319452364
Language:
English
URL:
Volltext
(lizenzpflichtig)
Bookmarklink
